• Synthesis of a series of degradable multivalent cationic lipids (CMVLs), 2+ to 5+
better understanding of their mechanism of action are required. We present the efficient synthesis of a series of degradable multivalent cationic lipids (CMVLn, n=2 to 5) containing a disulfide bond spacer between headgroup and lipophilic tails. This spacer is designed to be cleaved in the reducing milieu of the cytoplasm and thus decrease lipid toxicity. Small angle X-ray scattering demonstrates that the initially formed lamellar phase of CMVLn-DNA complexes completely disappears when reducing agents such as DTT or the biologically relevant reducing peptide glutathione are added to mimic the intracellular milieu. The CMVLs (n=3 to 5) exhibit reduced cytotoxicity and transfect mammalian cells with efficiencies comparable to those of highly efficient non-degradable analogues and benchmark commercial reagents such as Lipofectamine 2000. Thus, our results demonstrate that degradable disulfide spacers may be used to reduce the cytotoxicity of synthetic nonviral gene delivery carriers without compromising their transfection efficiency.
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Introduction
Gene therapy has the potential to address a wide variety of diseases at their root cause. These include cancer, hereditary disorders, and many others [1] [2] [3] [4] . However, despite massive efforts to the contrary, including numerous clinical trials worldwide [5, 6] , widespread therapeutic success has remained elusive. A key challenge for gene therapy is to develop efficient and safe gene delivery methods. Viral vectors, such as engineered adenoviruses and retroviruses, are very efficient (particularly in vivo) and have resulted in gene therapy's first successes [7] , but they suffer from a number of drawbacks. A primary concern is vector safety: in clinical trials, viral vectors have led to serious adverse effects, owing to immunogenicity and non-specific integration of their genetic cargo into the host genome [8] [9] [10] [11] . Other limitations are the small size of viral genomes and the comparatively difficult vector production. Synthetic nonviral vectors, on the other hand, lack immunogenic protein components, do not impose a size limit on the nucleic acid to be transferred, and are more easily prepared and modified. Their main limitation is their lower transfection efficiency (TE a , a measure of the amount of successfully transferred and transcribed DNA) and the onset of toxicity with increasing cationic lipid/nucleic acid mole ratios, which needs to be improved in order to compete with viral vectors [12] [13] [14] [15] .
a Abbreviations: Boc, tertButoxycarbonyl; CL, cationic liposome; DEAD, diethylazodicarboxylate; DIEA, N,N-diisopropylethylamine; DLS, dynamic light scattering; DOB, 3,4-Di(oleyloxy)benzoic acid; DOPC, 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine; DOTAP, 2,3-dioleoyloxypropyltrimethylammonium chloride; DTT, dithiothreitol; EtBr, ethidium bromide; GSH, glutathione; L/D, cationic lipid/DNA weight ratio; NA, nucleic acid; NL, neutral lipid; RLU, relative light units; SAXS, small-angle Xray scattering; TBTU, 2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate; TE, transfection efficiency; TFA, trifluoroacetic acid; TLC, thin-layer chromatography; TL/D, total lipid/DNA weight ratio; Φi, mole fraction of lipid i in the lipid mixture; σM, membrane charge density.
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Cationic liposome (CL)-nucleic acid (NA) complexes are one of the main classes of nonviral vectors [13, [16] [17] [18] [19] [20] . They form spontaneously when cationic liposomes (typically containing a neutral lipid (NL) as well as a cationic lipid) are combined with NAs. A large number of cationic lipids have been synthesized [21] [22] [23] to enhance the efficiency of CL-DNA complexes and uncover structure-TE relationships, albeit with limited success. Thus, further development of cationic lipid-based vectors is required to match the TE of viral vectors. Among the chemical approaches to improve the TE of CL-DNA complexes, the synthesis of cationic lipids with multivalent head groups has been particularly promising [24] [25] [26] [27] [28] [29] [30] .
The development of cationic lipids with low cytotoxicity is an important objective, especially for applications such as gene silencing which require higher cationic lipid/nucleic acid ratios [27] . The toxicity of CL-NA complexes is known to be due to the cationic lipid component of the complex [27, 31] . Thus, we hypothesized that triggered disintegration of an appropriately designed, degradable multivalent cationic lipid component of the CL-DNA complex upon entry into the cytoplasm should reduce cytotoxicity. At the same time, such lipids should retain high TE levels comparable to those of recently synthesized non-degradable multivalent lipids [24] [25] [26] [27] [28] [29] [30] because the key steps of lipid-mediated DNA delivery prior to cytoplasmic release-DNA compaction, complex uptake and endosomal escape [32, 33] -will not be compromised by the lipid degradation process.
In order to test this hypothesis and potentially decrease CL-induced cytotoxicity of lipid vectors, we prepared a series of cationic lipids designed to quickly degrade in the cytoplasm. As we describe, degradable multivalent lipids exhibit reduced toxicity with increasing cationic lipid/nucleic acid mole ratio while maintaining the high TE levels of previously synthesized multivalent lipids [24] [25] [26] [27] [28] [29] [30] , consistent with our hypothesis.
Cells maintain a high redox potential gradient between the intracellular (reducing) environment and extracellular (oxidizing) space. The main intracellular reducing agent is the short peptide glutathione (GSH), which is continually recycled [34] . The intracellular concentration of GSH varies for different tissues but can reach up to 5 mM (e.g. in the liver) [35, 36] . The redox potential gradient can be exploited to trigger, e.g., the cleavage of disulfide bonds in molecules once they reach the cytoplasm. This mechanism is used by biological toxins [37] as well as in drug delivery and diagnostic imaging [38] [39] [40] [41] [42] . A few studies have also applied the concept to gene delivery vectors [43] [44] [45] [46] , including CL-DNA complexes [47] [48] [49] [50] .
We report the convenient and efficient synthesis of a series of new degradable multivalent cationic lipids, termed CMVLn (n = 2 to 5). These CMVLs contain a reductively cleavable disulfide bond in the spacer between the hydrophobic moiety and the cationic head group. Reducing conditions result in separation of the hydrophobic tail from the headgroup. Except for the spacer, the CMVLs are identical to a previously synthesized series of multivalent lipids [32] . Of these, MVL5 in particular is a highly efficient vector for both DNA and siRNA [26, 27, 32] . The headgroup charge of the CMVLs was measured using an ethidium bromide (EtBr) displacement assay. CL-DNA complexes prepared from mixtures of the CMVLs with neutral 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC) were studied using small-angle X-ray scattering (SAXS) under reducing and non-reducing conditions, as well as measurements of cytotoxicity and TE. The CMVLs were compared with commercially available 2,3-dioleoyloxypropyltrimethylammonium chloride (DOTAP) and Lipofectamine 2000 as well as with non-degradable MVL5. All CMVL/DOPC-DNA complexes form lamellar phases ( C L α ) which can be completely disassembled by addition of reducing agents such as GSH
suspensions of a final concentration of 50 mM for X-ray samples. For transfection, aqueous lipid suspensions were prepared at 0.5 mM. Lipid mixtures containing higher mole fractions of DOPC formed opaque suspensions which were tip-sonicated to clarity (Vibra-cell, Sonics Materials). The aqueous lipid suspensions were stored at 4 °C until use.
Ethidium bromide displacement assay
Wells in a 96-well plate were preloaded with a mixture 2. 
Optical microscopy
For imaging of complexes with optical microscopy, 0.2 weight-% (of total lipid) DHPE-Texas Red (Avanti Polar Lipids) was added to the lipid mixture (before evaporation of the organic solvent). This fluorescent dye has an excitation/emission peak at 585/615 nm. Cy5 (Mirus Bio LLC), with an excitation/emission peak at 605/670 nm, was conjugated to DNA using the manufacturer's protocol. Complexes were then prepared as for transfection and imaged in Opti-MEM, 20 minutes after complex A C C E P T E D M A N U S C R I P T
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formation. Fluorescence intensity profiles of particles were obtained with the ImageJ
Color Profiler software tool.
Dynamic light scattering (DLS)
Complexes for DLS were prepared as for transfection but at a final concentration of 2 µg/mL of DNA (twice the concentration used for transfection, to achieve a sufficient particle concentration for the DLS measurement). The complexes were analyzed by DLS in Opti-MEM, 20 minutes after complex formation using a Malvern Nano ZS (173 degree scattering angle). The plot shows the z-average hydrodynamic diameter as obtained from the instrument. Data points shown are the average of duplicate measurements of the same sample, with error bars showing the standard deviation.
Small-angle X-ray scattering
High-resolution SAXS experiments were performed at the Stanford Synchrotron Radiation Lightsource. X-ray samples were prepared from 50 mM liposome solutions and 4 mg/mL DNA solutions, using 100 µg of DNA. CL-DNA complexes were formed by combining the CL and DNA solutions in microcentrifuge tubes, diluting 1-fold with Opti-MEM and incubating at 4 °C for at least 3 days after extensive centrifugation. For the samples containing reducing agents, GSH and DTT stock solutions were prepared at 300 mM and added to each sample after complex formation (after centrifugation) at a molar ratio of ≥ 10 over the CMVLs. Samples were then transferred into 1.5 mm quartz capillaries (Hilgenberg) and flame-sealed. Typically, the CL-DNA complexes formed a white opaque precipitate. Samples containing reducing agents occasionally exhibited phase separation of the initial precipitate. SAXS measurements were performed at multiple positions throughout the samples and representative scans are shown.
To assess the stability of CMVL-containing CL-DNA complexes (cf.
Supplementary Material), each X-ray sample was measured at least twice (unless the A C C E P T E D M A N U S C R I P T to control wells, which differed from the experimental wells only in that they were treated with Opti-MEM instead of complexes. All data points were measured as quadruplicates.
Cell transfection
Mouse fibroblast L-cells were cultured and transfected as previously reported [52] . 
Synthesis
General procedure for the deprotection of Boc-protected lipids. The protected lipid The combined EtOAc phases were washed twice with water, dried (Na2SO4) and evaporated in vacuo to yield 4.10 g (16.2 mmol, 45% ) of 3 as a white solid: Rf = 0.47 (CHCl3/MeOH 9:1, 1% concentrated NH4OH); NMR spectra matching literature data [54] . [26] and 289 mg (899 µmol) of TBTU in CH2Cl2 were added 116 µL (899 µmol) of DIEA with stirring. After 10 minutes, the resulting solution was added to a mixture of 812 mg (899 µmol) of 5 and 116 µL (899 µmol) of DIEA in CH2Cl2 and stirring was continued for 18 h.
N-(2-(((2S)-2-(2,5-Bis(3-aminopropylamino)pentanamido)ethyl)disulfanyl) ethyl)-{3,4-di(oleyloxy)benzamide} tetra-trifluoroacetate (CMVL4)
.
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(C(O)).
{4-[Bis-(3-tert-butoxycarbonylamino-propyl)amino](S)-1-[2-(2-{(3,4-di(oleyloxy)benzoyl)amino}-ethyldisulfanyl)-ethylcarbamoyl]-butyl}-(3-tertbutoxycarbonylamino-propyl)-carbamic acid tert-butyl ester (BocCMVL5). To a mixture of 575 mg (817 µmol) of Nα-Boc-Nα,Nδ,Nδ-tris(3-[Boc-amino]propyl)ornithine
The reaction mixture was extracted twice with 1 M aq NaH2PO4, once with water, twice with 5% NaHCO3, and once more with water. The organic phase was dried (Na2SO4), evaporated in vacuo and the residue purified by flash chromatography on 120 g of silica gel using CHCl3/MeOH (100:1) as the eluent to yield 643 mg (436 µmol, 52%) of 
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)
Results and discussion
Lipid design and synthesis
The CMVLn (n = 2 to 5) lipids presented in this study were designed to be stable in the extracellular environment but readily degrade in the reducing environment of the
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cytoplasm. We anticipated that this would reduce lipid toxicity and enhance nucleic acid release from their DNA complexes. The former is of practical importance (in particular for siRNA delivery [2] while the latter should shed light on the delivery pathway of multivalent lipids, particularly the limitations observed at high membrane charge density (σM) [32] . As evident from their chemical structures shown in Table 1 Figure 1 ). The synthesis proceeded by coupling DOB with mono-Bocprotected cystamine 3 [54] and Boc-deprotection to yield 5, the common precursor for the CMVLs. As exemplified for CMVL4 in Figure 1 , precursor 5 was coupled with the Boc-protected headgroup building blocks, and the resulting Boc-protected CMVLs were purified extensively and finally deprotected with TFA.
CL-DNA complexes were prepared from mixtures of the CMVLs and DOPC at varied mole fractions of CMVL (ΦCMVL = 1 -ΦDOPC) and using varying amounts of DNA.
The complexes were characterized using small-angle X-ray scattering, optical microscopy, and dynamic light scattering, and their cytotoxicity and transfection efficiency were assessed and compared to both MVL5 (a highly efficient, nondegradable analog of CMVL5 [26, 27, 32] and commercially available transfection M A N U S C R I P T
ACCEPTED MANUSCRIPT agents (DOTAP and Lipofectamine 2000). The chemical structures of MVL5, DOTAP
and DOPC are shown in the Supporting Information, Figure S1 .
Determination of the headgroup charge
An EtBr displacement assay [58, 59] was used to estimate the head group charge of the cationic lipids as reported previously [32] . EtBr fluoresces when intercalated into DNA but self-quenches in solution. Therefore, the fluorescence of a mixture of DNA and EtBr decreases when cationic lipids complex the DNA and displace the intercalated EtBr. When EtBr displacement is complete, the fluorescence reaches a baseline. The isoelectric point, where the positive charges on the lipids match the negative charges on the DNA, was determined as the onset of the baseline value as described [32] . 
Characterization of CL-DNA complexes by dynamic light scattering and optical microscopy
To unambiguously demonstrate that the lipids and DNA form complexes and to further characterize these complexes, we performed optical microscopy and dynamic light scattering (DLS) experiments. 
Small-angle X-ray scattering
We used SAXS to probe the structures of CMVL/DOPC-DNA complexes in the absence and presence of reducing agents. No signs of lipid phase separation could be detected; hence the complexes contained both CMVL and DOPC at the nominal ratios. at least 3 [60] [61] [62] [63] [64] . Taken together with the EtBr assay data, this means that only the cleaved headgroup of CMVL5 is able to condense the DNA. This permits assignment of the additional peak observed after reductive treatment. The position of this peak is
A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
consistent with the formation of hexagonal DNA bundles, as seen with, e.g., spermine, spermidine, and small poly(propyleneimine) dendrimers [65] . For the DTT-treated CMVL5/DOPC-DNA complexes, the observed peak corresponds to an interhelical distance of dDNA = 4π/ (3) 1/2 q = 31.2 Å in the bundles. A detailed, quantitative SAXS study of all CMVLs and their DNA complexes is in progress, and will be reported in due course.
Cytotoxicity
Cytotoxicity was measured by assessing cell viability with a tetrazolium salt-based assay [66] . Figure 6a shows the resulting data for DNA complexes (at ΦDOPC = 0) of MVL5 has previously been found to be a much better vector for gene silencing using siRNA than DOTAP, in part due to the lower toxicity of MVL5 at increased lipid/DNA charge ratios. The cleavable disulfide linker of CMVL5 reduced this toxicity even further.
Studies of the CMVLs as siRNA vectors are currently ongoing.
Cell transfection
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Transfection efficiency of CL-DNA complexes at varied L/D and ΦDOPC was measured using a luciferase assay. Figure 7 shows the resulting data for complexes of A C C E P T E D M A N U S C R I P T
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and CMVL3 is slightly closer to the TE achievable with CMVL4 and CMVL5 and exceeds the TE for optimized DOTAP complexes. Thus, as observed for the MVL series [32] , the TE of CMVL/DOPC-DNA complexes exhibits three regimes as a function of increasing ΦCMVL: initial increase, optimum TE, and a decrease at very high σM. Regarding the transfection mechanism, this suggests that lipid degradability (and, judging from the SAXS and cytotoxicity results, most likely intracellular degradation) does not affect the transfection mechanism. It appears that release of DNA from the lipids is not the factor limiting TE, since the drop in TE is not only observed for CMVL5 (for which condensation by the cleaved headgroup would still limit DNA release) but also for the other, less highly charged CMVLs.
In the light of their reduced cytotoxicity, the finding that the CMVLs with higher valency transfect cells as efficiently as non-degradable MVL5 and benchmark commercial lipids represents a major success. It suggests that the toxicity of a given lipid can be effectively reduced without negative impact on its efficiency by inserting a disulfide spacer between the lipid tails and headgroup.
Conclusions
We have presented the efficient synthesis of a series of new degradable multivalent cationic lipids, termed CMVLn (n = 2 to 5), which contain a disulfide-bond spacer between headgroup and the hydrophobic moiety. This spacer is cleaved by reducing agents such as the biologically relevant reducing peptide glutathione or DTT.
SAXS demonstrates that that the initially formed lamellar phase ( 
